Onconova Therapeutics Story Overview

ONTX -- USA Stock  

USD 0.53  0.032  6.40%

Macroaxis does not monitor all media channels or aggregates social signals for Onconova Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on Onconova Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Onconova Therapeutics. Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance.
Conversion by Michael Hoffman of 140449 shares of Onconova Therapeutics
Filed transaction by Onconova Therapeutics Inc director. Derivative codes conversion of derivative security

Onconova Therapeutics Inc insider trading alert for conversion of series c convertible preferred stock by Michael Hoffman, the corporate stakeholder, on March 8, 2018. This event was filed by Onconova Therapeutics Inc with SEC on 2013-08-01. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.94% . The trading delta at closing time when the story was published against the current closing price is 52.83% .

Similar stores for Onconova Therapeutics

a day ago at www.macroaxis.com 
Acquisition by Jerome Groopman of 87500 shares of Onconova Therapeutics subject to Rule 16b-3
Macroaxis News
Filed transaction by Onconova Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over a week ago at http://www.thestreetpoint.com 
Shocking Stocks Evofem Biosciences, Inc. , inTEST Corporation , TKK Symphony ...
Thestreet News
The Stock Street Full coverage
over two weeks ago at http://www.thestreetpoint.com 
That Will Motivate You Today- Agile Therapeutics, Inc. , Onconova Therapeutics, Inc. NASDAQ ...
Thestreet News
The Stock Street Full coverage
Have You Holding This Low Risky Stock Onconova Therapeuticsnews
Wallstreet InvestorplaceFull coverage
over two weeks ago at http://markets.businessinsider.com 
Sale by Michael Hoffman of 30000 shares of Onconova Therapeutics
businessinsider News
Filed transaction by Onconova Therapeutics Inc director. General open market or private sale of non-derivative or derivative security
over three weeks ago at http://www.streetinsider.com 
Onconova Therapeutics Announces Collaboration with Pint Pharma GmbH to Expand Rigosertib Clinical Trials ...
Street Insider News
StreetInsider.comAnalyst Research and Recommendations SORL Auto Parts, Inc. , Onconova Therapeutics, Inc. Analyst JournalOnconova Therapeutics Rating Reiterated by Maxim Group Fairfield CurrentFull coverage
over a month ago at http://dminute.com 
Kayne Anderson Capital Advisors LP Has Trimmed Its Genesis Energy LP Holding Onconova Therapeutics ...
D MinuteFull coverage
over a month ago at http://thewellesleysnews.com 
Analyst Stock Ratings DelMar Pharmaceuticals, Inc. , Onconova Therapeutics, Inc.
Analyst JournalFull coverage
over a month ago at http://www.thestreetpoint.com 
Why is the 50 Simple Moving Average so common for traders and analysts Turquoise Hill Resources Ltd ...
Thestreet News
The Stock Street Full coverage
over a month ago at http://nysedaily.com 
Should You Observe this stock Onconova Therapeutics, Inc.
NYSE DAILY Full coverage
over two months ago at http://cardinalweekly.com 
Lonestar Resources US Inc. Reaches 8.98 After 6.00 percent Up Move 2 Analysts Bullish Onconova Therapeutics .....
The Cardinal Weekly Analyst Research Roundup Onconova Therapeutics, Inc. , FleetCor Technologies, Inc. Analyst JournalFull coverage
over three months ago at http://www.stocksnewspoint.com 
Average True Range to Track Onconova Therapeutics, Inc. , Legacy Acquisition Corp ...
Stocks News Point Fruity Facts You Didnt Know about Morning Stocks Onconova Therapeutics, Inc. , AU Optronics Corp ... The Stock Street Why Onconova Therapeutics Incs Ownership Structure Is Important Simply Wall StFull coverage
Low Wild stock to watch Onconova Therapeutics, Inc.news
Wallstreet InvestorplaceTimpani Capital Management Has Boosted Merit Med Sys Com Position By 1.56 Million Last Week Onconova ... HuronReportFull coverage

Price to Earning

Price to Earning Comparative Analysis

Onconova Therapeutics is currently under evaluation in price to earning category among related companies. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.


Onconova Therapeutics Related Equities

EDGE  11.53 %   
DMPI  9.81 %   
ECYT  5.21 %   
DRNA  4.06 %   
CO  2.43 %   
DNLI  0.57 %   
DOVA  1.26 %   
EARS  1.64 %   
DVAX  1.86 %   
NK  4.3 %   
Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com